Global Viral Clearance Market 2018-2023 - Increasing Pharmaceutical Outsourcing & Emerging Markets Offer Opportunities


Dublin, Sept. 25, 2018 (GLOBE NEWSWIRE) -- The "Viral Clearance Market by Application (Recombinant Proteins, Blood, Vaccines), End User (Pharmaceutical & Biotechnology Companies, CROs), Method (Viral Removal (Chromatography, Nanofiltration), Viral Inactivation (Low pH)) - Global Forecasts to 2023" report has been added to ResearchAndMarkets.com's offering.

The global viral clearance market is expected to reach USD 724.5 million by 2023 from an estimated USD 271.2 million in 2018, at a CAGR of 21.7% during the forecast period.

Growth in the pharmaceutical and biotechnology industries, increasing number of new drug launches, R&D investments in life science, advancements in nanofiltration technology, and the high incidence and large economic burden of chronic diseases are expected to drive the growth of the viral clearance market. However, the high-cost requirements for drug development may hamper the pace of activity in this sector, and consequently the adoption of viral clearance practices.

On the basis of application, the global viral clearance market is segmented into recombinant proteins, blood and blood products, vaccines, and other applications. The other applications segment is expected to grow at the highest CAGR during the forecast period owing to the increasing use of cellular therapies in the treatment of cancer, hematologic malignancies, autoimmune disorders, and damaged tissue; growing industry focus on stem cell research; increasing awareness about stem cell therapies; and the use of tissue-based therapies to treat various diseases related to the kidneys, liver, heart, and lungs.

On the basis of method, the global viral clearance market is segmented into two broad categories - viral removal and viral inactivation. The viral removal segment is estimated to account for the largest share of the global viral clearance market in 2018. This segment is also expected to grow at the highest rate during the forecast period. The large share of this market segment is primarily attributed to the growth of biopharmaceutical R&D activities; high acceptance of this method; and the accuracy, speed, and flexibility provided by the method in life sciences research.

Asia Pacific is expected to witness the highest growth from 2018 to 2023, owing to increase in generics development and manufacturing, surge in Chinese funding for medical research, and presence of large number of CROs to provide preclinical and clinical research services in China, government initiatives to boost the use of generic drugs, increasing aging population in Japan, rise in pharmaceutical R&D expenditures in India, and the growing pharmaceutical manufacturing in Singapore and Malaysia.

The report analyzes the viral clearance market and aims at estimating the market size and future growth potential of this market based on various segments such as application, end user, method, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

4.1 Viral Clearance Market Overview
4.2 Asia Pacific: Viral Clearance Market, By Country and End User
4.3 Geographic Snapshot: Viral Clearance Market
4.4 Viral Clearance Market, By Application (2018 vs 2023)

5 Market Overview

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growth in the Pharmaceutical and Biotechnology Industries
5.2.1.2 Increasing Number of Drug Launches
5.2.1.3 Favorable R&D Investment Scenario
5.2.1.4 Possibility of Cell Culture Contamination
5.2.1.5 Advancements in Nanofiltration Technology
5.2.1.6 High Incidence and Large Economic Burden of Chronic Diseases
5.2.2 Restraints
5.2.2.1 Cost and Time-Intensive Drug Development Process
5.2.3 Opportunities
5.2.3.1 Increasing Pharmaceutical Outsourcing
5.2.3.2 Emerging Markets
5.2.4 Challenges
5.2.4.1 Dearth of Skilled Professionals

6 Viral Clearance Market, By Application

6.1 Introduction
6.2 Recombinant Proteins
6.3 Blood and Blood Products
6.4 Vaccines
6.5 Other Applications

7 Viral Clearance Market, By End User

7.1 Introduction
7.2 Pharmaceutical & Biotechnology Companies
7.3 Contract Research Organizations
7.4 Academic Research Institutes
7.5 Other End Users

8 Viral Clearance Market, By Method

8.1 Introduction
8.2 Viral Removal
8.2.1 Chromatography
8.2.2 Nanofiltration
8.2.3 Precipitation
8.3 Viral Inactivation
8.3.1 Low Ph
8.3.2 Solvent Detergent Method
8.3.3 Pasteurization
8.3.4 Other Viral Inactivation Methods

9 Viral Clearance Market, By Region

9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 UK
9.3.4 RoE
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 RoAPAC
9.5 RoW

10 Competitive Landscape

10.1 Introduction
10.2 Viral Clearance Market Share Analysis (2017)
10.2.1 Wuxi Biologics (Cayman)
10.2.2 Merck KGaA
10.2.3 Charles River Laboratories International Inc.
10.3 Competitive Scenario

11 Company Profiles

11.1 Wuxi Biologics (Cayman) (Subsidiary of Wuxi Apptec)
11.2 Merck KGaA
11.3 Charles River Laboratories International
11.4 Kedrion
11.5 Vironova Biosafety
11.6 Texcell
11.7 Clean Cells
11.8 Bsl Bioservice
11.9 Virusure GmbH

For more information about this report visit https://www.researchandmarkets.com/research/927hrb/global_viral?w=12

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.


            

Contact Data